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Comprehensive mutational analysis  
of CDKN2A and CDK4 in Greek patients  
with cutaneous melanoma
Three hundred and four single primary melanoma (SPM) cases 
and 16 genetically enriched cases [seven patients with multiple 
primary melanoma (MPM) and nine with familial melanoma 
(FM)] were evaluated. Germline CDKN2A mutations were 
detected in 10 of 304 SPM, in four of seven MPM and in two 
of nine FM cases. The most common mutation was a Northern 
European allele (p16 p.R24P) detected in eight individuals. Five 
previously unreported CDKN2A variants were identified as well 
as the first report of a CDK4 p.R24H substitution in a Greek fam-
ily. This study supports a role for CDKN2A and CDK4 mutations 
in susceptibility to melanoma among Greek individuals. Br J 
Dermatol 2011; 165: 1219–22.
Blue-black rule: a simple dermoscopic clue  
to recognize pigmented nodular melanoma
Dermoscopic images of 283 histopathologically diagnosed 
pigmented nodular tumours were evaluated for the pres-
ence of standard melanoma criteria and for the presence of 
a new feature named blue-black (BB) colour. Presence of the 
BB feature had 78.2% sensitivity for melanoma compared 
with a sensitivity of 43.6% achieved by the standard mela-
noma criteria. A combined method based on the presence of 
either the BB feature or one (or more) of the standard mela-
noma criteria reached a sensitivity of 84.6%, with specific-
ity of 80.5% and negative predictive value of 93.2%. The 
combined method gave specificity and positive predictive 
value for malignancy of 91.9% and 90.6%, respectively. Br J 
Dermatol 2011; 165: 1251–55.
Herlitz junctional epidermolysis bullosa: 
diagnostic features, mutational profile, 
incidence and population carrier frequency  
in the Netherlands
The diagnostic features of 22 patients with junctional epi-
dermolysis bullosa, type Herlitz (JEB-H) in the Dutch 
Epidermolysis Bullosa Registry between 1988 and 2011 are 
reported. The mean lifespan was 5.8 months (range 0.5–32.6). 
Mutations were identified in all 22 patients, with a total 
of 11 different mutations in LAMB3, LAMC2 and LAMA3. 
Three novel splice site mutations in LAMB3 are reported. 
The incidence of JEB-H in the Netherlands is 4.0 new cases 
per million live births and the carrier frequency of a JEB-H 
mutation is 1 in 249. Br J Dermatol 2011; 165: 1315–23.
Susceptibility variants on chromosome 7p21.1 
suggest HDAC9 as a new candidate gene for 
male-pattern baldness
This genome-wide association study suggests that the histone 
deacetylase 9 (HDAC9) gene is the third male-pattern bald-
ness [androgenetic alopecia (AGA)] susceptibility gene. A 
German sample of 581 severely affected cases and 617 con-
trols was investigated. The most significant association signal 
was obtained for rs756853 which is located intro nically in 
HDAC9. Fine-mapping and a family-based analysis revealed 
that rs756853 and the 6-kb distal rs2249817 were the 
most highly associated single nucleotide polymorphisms. 
The association finding was replicated in an indepen-
dent Australian sample, when the analysis was restricted to 
severely affected cases and unaffected controls (P = 0.026). 
Analysis of rs2249817 in a combined sample of severely 
affected German and Australian cases and unaffected con-
trols revealed a strong association signal (P = 9.09 x 10-8). 
Tissue expression studies demonstrated HDAC9 expression 
in various tissues, including tissues of relevance to AGA. 
Pathway analyses led to the hypothesis that HDAC9 plays 
a functional role in AGA via interaction with the androgen 
receptor gene. Br J Dermatol 2011; 165: 1293–302.
